Cristina Ples

Dr. Cristina Ples

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
CPCristina Ples
Cristina Ples
CSCristina Elena Savencu
Cristina Elena Savencu
PAPAH ANA-MARIA
PAH ANA-MARIA
GSGheorghe Stoichescu-Hogea
Gheorghe Stoichescu-Hogea
Diana - Maria MateescuDiana - Maria Mateescu
Diana - Maria Mateescu
Roxana OanceaRoxana Oancea
Roxana Oancea
Background/Objectives: Periodontal disease is a chronic inflammatory condition associated with systemic vascular dysfunction and elevated cardiovascular risk. This systematic review and meta-analysis aimed to quantitatively evaluate the association between periodontitis and endothelial dysfunction and to assess the effects of periodontal therapy on endothelial function and inflammatory biomarkers. Methods: Conducted per PRISMA 2020 and registered in PROSPERO (CRD420261309247). Electronic databases (PubMed, Scopus, Cochrane Library) were searched for observational and interventional studies assessing endothelial function in patients with periodontitis. Risk of bias was evaluated using RoB 2, ROBINS-I, and the Newcastle–Ottawa Scale; certainty of evidence was assessed with GRADE. Pooled effects on flow-mediated dilation (FMD) and inflammatory markers were estimated using random-effects meta-analysis (DerSimonian–Laird). Results: Fourteen studies were included in qualitative synthesis; six contributed quantitative FMD data. Observational studies consistently demonstrated impaired endothelial function and elevated inflammatory markers in patients with periodontitis versus controls. Meta-analysis showed that periodontal therapy significantly improved endothelial function (pooled FMD: +3.3 percentage points; 95% CI 1.7–4.9; I2 = 77%; p < 0.001), though results should be interpreted cautiously given substantial heterogeneity and the limited number of studies (n = 6). Periodontal treatment reduced CRP levels (mean difference −0.38 mg/L; I2 = 41%); IL-6 showed a favorable direction but with very low certainty of evidence. Publication bias could not be reliably assessed given the small number of included studies. Conclusions: Periodontitis is associated with impaired endothelial function and systemic inflammation. Periodontal therapy leads to measurable improvements in both, supporting its role as a potentially modifiable contributor to cardiovascular risk. Larger randomized trials with long-term cardiovascular endpoints are warranted.

13 September 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
GSGheorghe Stoichescu-Hogea
Gheorghe Stoichescu-Hogea
CLCRACIUN Maria Laura
CRACIUN Maria Laura
PAPAH ANA-MARIA
PAH ANA-MARIA
CACristiana Adina Avram
Cristiana Adina Avram
MRMARIA RADA
MARIA RADA
Simona DrãganSimona Drãgan
Simona Drãgan
Background/Objectives: We compared BMI and LDL-C across database-defined reference controls, hypertension, and preserved-EF ischemic heart disease without assuming HFpEF. Methods: This single-center retrospective cross-sectional study included 128 adults (20 controls, 46 with hypertension, and 62 in the preserved-EF ischemic group). Analyses included nonparametric tests, multinomial regression, clinical-group models with and without statin adjustment, and a post hoc common-age sensitivity analysis. Results: Median BMI was 25.89, 28.25, and 29.00 kg/m2, respectively (p < 0.001); median LDL-C was 86.0, 109.5, and 100.0 mg/dL (p = 0.055), alongside statin use of 0%, 50.0%, and 87.1%. Per 5 kg/m2 higher BMI, the adjusted RRR for preserved-EF ischemic versus control status was 3.94 (95% CI 1.60–9.71; p = 0.003) and remained 3.48 (95% CI 1.35–8.97; p = 0.010) among participants aged 40–68 years. In clinical-group models, BMI estimates were similar without and with statin adjustment (OR 1.76 and 1.89); LDL-C was not independently associated with preserved-EF ischemic status. Conclusions: BMI differed more consistently across groups than treated, contemporaneous LDL-C. These associations are imprecise and describe group status; they do not establish causation, progression, prospective HF risk, or HFpEF.

Verified
Journal Article
Open access
PDF file
GOGabriela Otiman
Gabriela Otiman
Ciprian Ilie RoscaCiprian Ilie Rosca
Ciprian Ilie Rosca
Daniel Dumitru NisulescuDaniel Dumitru Nisulescu
Daniel Dumitru Nisulescu
MAMahmoud Emad Abdeldayem
Mahmoud Emad Abdeldayem
PAPAH ANA-MARIA
PAH ANA-MARIA
GSGheorghe Stoichescu-Hogea
Gheorghe Stoichescu-Hogea
Background/Objectives: European guidelines recommend increasingly stringent, risk-stratified low-density lipoprotein cholesterol (LDL-C) targets, but real-world attainment remains suboptimal. We evaluated 12-month lipid-target attainment and changes in model-derived cardiovascular risk estimates in an ambulatory dyslipidaemia cohort. Methods: In this prospective, single-centre observational study, 101 consecutive adults were assessed at baseline and after at least 12 months of routine-care lipid-lowering therapy. Patients were classified as moderate/low, high, or very high cardiovascular risk. The primary endpoint was attainment of the risk-specific LDL-C target at 12 months versus baseline. Paired changes were tested using the McNemar exact and Wilcoxon signed-rank tests. Multivariable logistic regression assessed correlates of target attainment, with Firth penalisation used because of sparse outcomes in the higher risk strata. Results: LDL-C target attainment increased from 6.0% to 43.0%, and non-HDL-C attainment from 7.0% to 51.5% (both p < 0.001). At 12 months, 89% of moderate/low-risk patients reached the LDL-C target, compared with 9% of high-risk and 23% of very-high-risk patients (p < 0.001). Higher risk category was strongly associated with non-attainment, although the odds ratios were imprecise because of sparse events. Only one patient received a high-intensity statin and three received a PCSK9 inhibitor, despite 63% of the cohort being at high or very high risk. Model-derived risk scores decreased, partly as a mathematical consequence of updated lipid inputs. Therapy was well tolerated. Conclusions: Lipid control improved substantially, but target attainment remained poorest in patients at greatest cardiovascular risk. Earlier treatment intensification, structured adherence assessment, and more consistent use of combination therapy may reduce this implementation gap.

9 November 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
GSGheorghe Stoichescu-Hogea
Gheorghe Stoichescu-Hogea
PAPAH ANA-MARIA
PAH ANA-MARIA
Dana Emilia MovilaDana Emilia Movila
Dana Emilia Movila
CSCristina Elena Savencu
Cristina Elena Savencu
CPCristina Ples
Cristina Ples
Simona DrãganSimona Drãgan
Simona Drãgan
Background/Objectives: Carotid plaque and aortic pulse wave velocity (PWV) capture distinct aspects of vascular disease. We examined their associations with left ventricular global longitudinal strain (GLS) in adults with ejection fraction ≥50%. Methods: This single-center retrospective cross-sectional secondary analysis used the 2018–2019 institutional cohort, comprising preserved-EF ischemic heart disease, hypertension, and reference control groups. The primary outcome was signed GLS, for which a higher (less negative) value indicates worse shortening. Multivariable linear regression simultaneously included plaque and PWV, adjusting for age, sex, systolic blood pressure, diabetes, and source group; HC3 robust confidence intervals were used. Results: Of 128 records, 127 had evaluable PWV and GLS. Mean age was 60.8 years; 51/127 (40.2%) were women, and 37/127 (29.1%) had recorded plaque. PWV correlated with GLS (Pearson r = 0.426; p < 0.001). Adjusted GLS was 0.618 percentage points less negative per 1 m/s higher PWV (95% CI 0.280–0.956; p < 0.001). Plaque presence had no clearly detectable independent association (β = −0.348, 95% CI −1.358 to 0.661; p = 0.499). Conclusions: Higher aortic PWV was associated with less favorable longitudinal function despite preserved ejection fraction. The plaque estimate was imprecise. Cross-sectional data cannot establish temporal order or causality, and the historical ICpFE label does not independently validate an HFpEF diagnosis.